Ayrton Capital LLC Pharma Cyte Biotech, Inc. Put Options Transaction History
Ayrton Capital LLC
- $2.64 Million
- Q3 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PMCB
# of Institutions
29Shares Held
674KCall Options Held
13.7KPut Options Held
2.1K-
Vanguard Group Inc Valley Forge, PA195KShares$219,8050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA139KShares$156,9960.0% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$93,4810.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.5KShares$55,9340.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY25.5KShares$28,8140.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $23.4M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...